OT-I T cells are transgenic T cells with T Cell Receptor (TCR) specificity for the SIINFEKL epitope of OVA presented in the context of H-2Kb Class I MHC by B16-OVA tumour cells53, 54 (Fig. 2D). The gene discussed is HLA-C; the disease is neoplasm.